Annarita Nappi

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Fortunato Ciardiello, Nicola Normanno, Erika Martinelli et al. · Annals of Oncology · 2016 · 97 citations

Gastrointestinal Oncology, Cetuximab Continuation, Medicine +8

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer

Caterina Miro, A Giovanni, Melania Murolo et al. · Cancer Letters · 2022 · 73 citations

Androgen Signals, Thyroid Disease, Pathology +7

Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch

Caterina Miro, Emery Di Cicco, Raffaele Ambrosio et al. · Nature Communications · 2019 · 64 citations · Full text

The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress

Serena Sagliocchi, Annunziata Gaetana Cicatiello, Emery Di Cicco et al. · Redox Biology · 2019 · 56 citations · Full text

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

Claudia Cardone, Bernadette Blauensteiner, Verónica Moreno‐Viedma et al. · European Journal of Cancer · 2020 · 48 citations

Medicine, Pathology, Colorectal Cancer +7